Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

437 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Central nervous system atrophy and clinical status in multiple sclerosis.
Zivadinov R, Bakshi R. Zivadinov R, et al. J Neuroimaging. 2004 Jul;14(3 Suppl):27S-35S. doi: 10.1177/1051228404266266. J Neuroimaging. 2004. PMID: 15228757 Review.
Olfactory loss in multiple sclerosis.
Zivadinov R, Zorzon M, Monti Bragadin L, Pagliaro G, Cazzato G. Zivadinov R, et al. J Neurol Sci. 1999 Oct 15;168(2):127-30. doi: 10.1016/s0022-510x(99)00189-6. J Neurol Sci. 1999. PMID: 10526195
Significant correlations between the smell identification score and symptoms of anxiety (r=-0.43, P=0.006), depression (r=-0.42, P=0. 008) and severity of neurological impairment (r=-0.32, P=0.05) were found. ...
Significant correlations between the smell identification score and symptoms of anxiety (r=-0.43, P=0.006), depression (r=-0.4 …
Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups.
Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Morassi P, Iona LG, Cazzato G. Zorzon M, et al. Among authors: zivadinov r. Mult Scler. 1999 Dec;5(6):418-27. doi: 10.1177/135245859900500i609. Mult Scler. 1999. PMID: 10618699
Sexual dysfunction in multiple sclerosis: II. Correlation analysis.
Zivadinov R, Zorzon M, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Iona LG, Cazzato G. Zivadinov R, et al. Mult Scler. 1999 Dec;5(6):428-31. doi: 10.1177/135245859900500i610. Mult Scler. 1999. PMID: 10618700
Sexual dysfunction directly correlated with presence of physical disorders (r=0.37, P=0.0004), low educational level (r=0.32, P<0.002), disability (r=0.31, P<0.003), age at onset of symptoms (r=0.30, P<0.003), sphincteric dysfunction (r
Sexual dysfunction directly correlated with presence of physical disorders (r=0.37, P=0.0004), low educational level (r=0.32, …
Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study.
Zorzon M, Ukmar M, Bragadin LM, Zanier F, Antonello RM, Cazzato G, Zivadinov R. Zorzon M, et al. Among authors: zivadinov r. Mult Scler. 2000 Dec;6(6):386-90. doi: 10.1177/135245850000600605. Mult Scler. 2000. PMID: 11212134
RESULTS: A robust correlation was demonstrated between MR measures of lesion load in the white matter of the olfactory brain region and smell loss (r=-0. 739, P<0.0001). A significant relationship has been found even after taking potential confounding factors, such as s …
RESULTS: A robust correlation was demonstrated between MR measures of lesion load in the white matter of the olfactory brain region and smel …
MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. Zivadinov R, et al. Neuroradiology. 2001 Apr;43(4):272-8. doi: 10.1007/s002340000500. Neuroradiology. 2001. PMID: 11338408
Multiple regression analysis models demonstrated that the only variables independently correlated with cognitive impairment were: BPF (R = 0.89, P = 0.001) and average NABT MTR (R = 0.76, P = 0.012). ...
Multiple regression analysis models demonstrated that the only variables independently correlated with cognitive impairment were: BPF (R
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. Zivadinov R, et al. J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):773-80. doi: 10.1136/jnnp.70.6.773. J Neurol Neurosurg Psychiatry. 2001. PMID: 11385012 Free PMC article.
The cognitive impairment was independently predicted over 2 years only by the change of brain parenchymal volumes (R=0.51, p=0.0003). ...At the end of the study the loss of brain parenchyma correlated significantly with change in EDSS (r= 0.59, p<0.0001). CONCLUS …
The cognitive impairment was independently predicted over 2 years only by the change of brain parenchymal volumes (R=0.51, p=0.0003). …
Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects.
Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, Bratina A, Zivadinov R. Zorzon M, et al. Among authors: zivadinov r. J Neurol. 2001 May;248(5):416-21. doi: 10.1007/s004150170184. J Neurol. 2001. PMID: 11437165
Both severity of depressive symptoms and diagnosis of major depression correlated, albeit weakly, with right frontal lesion load (r=0.22, p=0.035, and r=0.23, p=0.026, respectively) and right temporal brain volume (r=0.22, p=0.005 and r=0.22, p=0.036, …
Both severity of depressive symptoms and diagnosis of major depression correlated, albeit weakly, with right frontal lesion load (r=0 …
Sexual dysfunction in multiple sclerosis: a 2-year follow-up study.
Zorzon M, Zivadinov R, Monti Bragadin L, Moretti R, De Masi R, Nasuelli D, Cazzato G. Zorzon M, et al. Among authors: zivadinov r. J Neurol Sci. 2001 Jun 15;187(1-2):1-5. doi: 10.1016/s0022-510x(01)00493-2. J Neurol Sci. 2001. PMID: 11440738
In the univariate analysis, changes in sexual function over time correlated with changes in bladder function (r=0.47, p<0.0001) and EDSS score (r=0.41, p<0.0001), but the multivariate analysis demonstrated that only bladder dysfunction was independently relate …
In the univariate analysis, changes in sexual function over time correlated with changes in bladder function (r=0.47, p<0.0001) an …
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.
Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. Zivadinov R, et al. Neurology. 2001 Oct 9;57(7):1239-47. doi: 10.1212/wnl.57.7.1239. Neurology. 2001. PMID: 11591843 Clinical Trial.
437 results
Jump to page
Feedback